Literature DB >> 30630980

FLT3 ligand plasma levels in acute myeloid leukemia.

Pierre Peterlin1,2, Joelle Gaschet2, Thierry Guillaume3,2, Alice Garnier3, Marion Eveillard2,4, Amandine Le Bourgeois3, Michel Cherel2,5, Camille Debord4, Yannick Le Bris2,4, Olivier Theisen4, Béatrice Mahé3, Viviane Dubruille3, Catherine Godon4, Nelly Robillard4, Soraya Wuilleme4, Cyrille Touzeau3, Thomas Gastinne3, Nicolas Blin3, Anne Lok3, Antoine Bonnet3, Steven Le Gouill3,2, Philippe Moreau3,2, Marie-C Béné2,4, Patrice Chevallier3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30630980      PMCID： PMC6545831          DOI： 10.3324/haematol.2018.209460

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  (90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.

Authors:  Patrice Chevallier; Thomas Eugene; Nelly Robillard; Françoise Isnard; Franck Nicolini; Martine Escoffre-Barbe; Françoise Huguet; Mathilde Hunault; Antoine Marcais; Joelle Gaschet; Michel Cherel; Thierry Guillaume; Jacques Delaunay; Pierre Peterlin; Marion Eveillard; Xavier Thomas; Norbert Ifrah; Simona Lapusan; Caroline Bodet-Milin; Jacques Barbet; Alain Faivre-Chauvet; Ludovic Ferrer; Marie C Bene; Claire Le Houerou; David M Goldenberg; William A Wegener; Françoise Kraeber-Bodéré
Journal:  Lancet Haematol       Date:  2015-02-25       Impact factor: 18.959

2.  Kinetics of plasma FLT3 ligand concentration in hematopoietic stem cell transplanted patients.

Authors:  Marie Prat; Johanna Frick; Jean-Philippe Laporte; Dominique Thierry; Norbert-Claude Gorin; Jean-Marc Bertho
Journal:  Leuk Lymphoma       Date:  2006-01

3.  Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia.

Authors:  J M Bertho; C Demarquay; J Frick; C Joubert; S Arenales; N Jacquet; I Sorokine-Durm; Q Chau; M Lopez; J Aigueperse; N C Gorin; P Gourmelon
Journal:  Int J Radiat Biol       Date:  2001-06       Impact factor: 2.694

4.  FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo.

Authors:  Takashi Sato; Xiaochuan Yang; Steven Knapper; Paul White; B Douglas Smith; Steven Galkin; Donald Small; Alan Burnett; Mark Levis
Journal:  Blood       Date:  2011-01-24       Impact factor: 22.113

5.  Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.

Authors:  G Meierhoff; U Dehmel; H J Gruss; O Rosnet; D Birnbaum; H Quentmeier; W Dirks; H G Drexler
Journal:  Leukemia       Date:  1995-08       Impact factor: 11.528

Review 6.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

8.  FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells.

Authors:  Rui Zheng; Mark Levis; Obdulio Piloto; Patrick Brown; Brenda R Baldwin; Norbert C Gorin; Miloslav Beran; Zhenping Zhu; Dale Ludwig; Dan Hicklin; Larry Witte; Yiwen Li; Donald Small
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

9.  Serum Flt3 ligand variation as a predictive indicator of hematopoietic stem cell mobilization.

Authors:  Joud H Haidar; Ali Bazarbachi; Rami Mahfouz; Hounaida Abi Haidar; Hassan Jaafar; Rose Daher
Journal:  J Hematother Stem Cell Res       Date:  2002-06

10.  Expression of the flt3 receptor and its ligand on hematopoietic cells.

Authors:  K Brasel; S Escobar; R Anderberg; P de Vries; H J Gruss; S D Lyman
Journal:  Leukemia       Date:  1995-07       Impact factor: 11.528
View more
  4 in total

Review 1.  Gilteritinib: potent targeting of FLT3 mutations in AML.

Authors:  Mark Levis; Alexander E Perl
Journal:  Blood Adv       Date:  2020-03-24

2.  FLT3-ITD Mutation and FLT3 Ligand Plasma Level Were Not Associated with One-Year Survival of Indonesian Acute Myeloid Leukemia Patients.

Authors:  Ikhwan Rinaldi; Melva Louisa; Resti Mulya Sari; Elly Arwanih
Journal:  Onco Targets Ther       Date:  2021-02-26       Impact factor: 4.147

3.  A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.

Authors:  Pierre Peterlin; Joelle Gaschet; Thierry Guillaume; Alice Garnier; Marion Eveillard; Amandine Le Bourgeois; Michel Cherel; Camille Debord; Yannick Le Bris; Olivier Theisen; Catherine Godon; Béatrice Mahé; Viviane Dubruille; Soraya Wuilleme; Cyrille Touzeau; Thomas Gastinne; Nicolas Blin; Anne Lok; Benoît Tessoulin; Steven Le Gouill; Philippe Moreau; Marie-C Béné; Patrice Chevallier
Journal:  Cancer Med       Date:  2020-12-25       Impact factor: 4.452

4.  Cytokine Imprint in Preeclampsia.

Authors:  Katarzyna Stefańska; Maciej Zieliński; Martyna Jankowiak; Dorota Zamkowska; Justyna Sakowska; Przemysław Adamski; Joanna Jassem-Bobowicz; Karolina Piekarska; Katarzyna Leszczyńska; Renata Świątkowska-Stodulska; Sebastian Kwiatkowski; Krzysztof Preis; Piotr Trzonkowski; Natalia Marek-Trzonkowska
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.